Cero Therapeutics Holdings, Inc.

Venture-backed company · Stage unknown· South San Francisco, CA
Rounds on record
2
Latest round
Apr 22, 2025
Form D equity offering
Latest round size
$5.0M
Form D industry: Pharmaceuticals
More
Ask DFX about thisView relationshipsFinancing historyInvestorsOwnership and outcomes
As of · the latest observation of this company; each round carries its own date

7 additional officers and directors

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. 1 investor
    named

    1 investor on record.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
  2. 9 directors
    board

    9 directors on record from Form D filings and board-seat attributions.

    The board is who decides on the next round and on a sale.

    FactSEC Form D related personsFor Investors, acquirersPeople →
Drawing the relationship network…

Facts

Year of incorporation
2021sec.gov
Revenue range (Form D)
No Revenuessec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1

Financing history

2 rounds
  1. Apr 22, 2025
    Form D equity offering · $5.0M (form d sold) · 5 investors
    Fact Form D · “Cero Therapeutics Holdings, Inc. filed Form D: $5,000,000 sold of $8,000,000, Pharmaceuticals”
  2. Sep 26, 2024
    Form D equity offering · $1.3M (form d sold) · 13 investors
    Fact Form D · “Cero Therapeutics Holdings, Inc. filed Form D: $1,250,000 sold of $1,250,000, Pharmaceuticals”

Investors on record

1 edge

Ownership and outcomes

none on record
Outcome stated by investors

No firm portfolio page lists this company, so no outcome is stated.

No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.

Credit relationships

none on record
No lender position matched to this company.

People

4 officers, 9 directors
Show all 6 officers and directors

Timeline

2 events
  1. May 6, 2025
    Cero Therapeutics Holdings, Inc. filed Form D: $5,000,000 sold of $8,000,000, Pharmaceuticals
    Form D filed Fact Form D
  2. Oct 4, 2024
    Cero Therapeutics Holdings, Inc. filed Form D: $1,250,000 sold of $1,250,000, Pharmaceuticals
    Form D filed Fact Form D

Evidence

30 observations
Every observation on this company
  • Entity type: Corporation May 6, 2025 Fact Form D
  • Entity type: Corporation Oct 4, 2024 Fact Form D
  • Form D industry group: Pharmaceuticals May 6, 2025 Fact Form D
  • Form D industry group: Pharmaceuticals Oct 4, 2024 Fact Form D
  • Amendment: false May 6, 2025 Fact Form D
  • Amendment: false Oct 4, 2024 Fact Form D
  • Revenue range (Form D): No Revenues May 6, 2025 Fact Form D
  • Revenue range (Form D): No Revenues Oct 4, 2024 Fact Form D
  • Incorporated: withinFiveYears May 6, 2025 Fact Form D
  • Incorporated: withinFiveYears Oct 4, 2024 Fact Form D
  • Jurisdiction: Delaware May 6, 2025 Fact Form D
  • Jurisdiction: Delaware Oct 4, 2024 Fact Form D
  • Amount sold (Form D): $5.0M May 6, 2025 Fact Form D
  • Amount sold (Form D): $1.3M Oct 4, 2024 Fact Form D
  • Offering amount (Form D): $8.0M May 6, 2025 Fact Form D
  • Offering amount (Form D): $1.3M Oct 4, 2024 Fact Form D
  • Exemptions: 06b May 6, 2025 Fact Form D
  • Exemptions: 06b Oct 4, 2024 Fact Form D
  • First sale: 2025-04-22 May 6, 2025 Fact Form D
  • First sale: 2024-09-26 Oct 4, 2024 Fact Form D
  • Investors (Form D): 5 May 6, 2025 Fact Form D
  • Investors (Form D): 13 Oct 4, 2024 Fact Form D
  • Minimum investment (Form D): 0 May 6, 2025 Fact Form D
  • Minimum investment (Form D): 1,000 Oct 4, 2024 Fact Form D
  • Securities offered: equity May 6, 2025 Fact Form D
  • Securities offered: Equity, option Oct 4, 2024 Fact Form D
  • Office address: May 6, 2025 Fact Form D
  • Office address: Oct 4, 2024 Fact Form D
  • Year of incorporation: 2021 May 6, 2025 Fact Form D
  • Year of incorporation: 2021 Oct 4, 2024 Fact Form D

Relationships across DFX

on 1 other DFX graph · 2 capital paths
Across the graphs

Cero Therapeutics Holdings, Inc. is the same institution as 1 record in Allocators.

Allocators1

The joined record opens with the product, beside every other relationship on this page.

Checking your plan…

Capital chain

Cero Therapeutics Holdings, Inc. sits on 2 traced paths of capital across the graphs.

Allocator to VC fund to manager to company

DFX traced 2 paths of capital through this record

Every record on each path, what it committed or lent, and as of when.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Derived from allocator disclosures, BDC schedules and SEC filings; confidence is the weakest hop.

Checking your plan…

Record history

2 dated events on the change ledger, latest event first
  • Form D filed
    2025-05-06source on record
  • Form D filed
    2024-10-04source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.